A new dimeric neolignan from Magnolia grandiflora L. seeds

Arch Pharm Res. 2015 Jun;38(6):1066-71. doi: 10.1007/s12272-014-0476-4. Epub 2014 Sep 6.

Abstract

Bioassay-guided fractionation of the MeOH extract of Magnolia grandiflora seeds resulted in the isolation of a new dimeric neolignan, named bishonokiol A (1), as well as two known neolignans magnolol (2) and honokiol (3). The structures of the compounds were determined on the basis of data obtained using NMR and MS. Bishonokiol A (1) showed potent anti-proliferative activities in four human cancer cell lines, with IC50 values ranging from 5.1 to 7.5 µM. Additionally, bishonokiol A (1) induced apoptosis, as well as down-regulated the expression of the anti-apoptotic protein Bcl-2 and caspase-3 cleavage in HepG2 cell line.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects
  • Biphenyl Compounds / chemistry
  • Biphenyl Compounds / isolation & purification
  • Caspase 3 / biosynthesis
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival
  • Down-Regulation / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Lignans / chemistry*
  • Lignans / isolation & purification
  • Lignans / pharmacology
  • Magnolia / chemistry*
  • Molecular Conformation
  • Plant Extracts / chemistry
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Seeds / chemistry

Substances

  • Antineoplastic Agents, Phytogenic
  • Biphenyl Compounds
  • Lignans
  • Plant Extracts
  • Proto-Oncogene Proteins c-bcl-2
  • bishonokiol A
  • magnolol
  • honokiol
  • Caspase 3